BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31033959)

  • 1. Genome Editing in Mammalian Cell Lines using CRISPR-Cas.
    Liu KI; Sutrisnoh NB; Wang Y; Tan MH
    J Vis Exp; 2019 Apr; (146):. PubMed ID: 31033959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Versatile and precise gene-targeting strategies for functional studies in mammalian cell lines.
    Wassef M; Luscan A; Battistella A; Le Corre S; Li H; Wallace MR; Vidaud M; Margueron R
    Methods; 2017 May; 121-122():45-54. PubMed ID: 28499832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods Favoring Homology-Directed Repair Choice in Response to CRISPR/Cas9 Induced-Double Strand Breaks.
    Yang H; Ren S; Yu S; Pan H; Li T; Ge S; Zhang J; Xia N
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision genome editing in the CRISPR era.
    Salsman J; Dellaire G
    Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized design parameters for CRISPR Cas9 and Cas12a homology-directed repair.
    Schubert MS; Thommandru B; Woodley J; Turk R; Yan S; Kurgan G; McNeill MS; Rettig GR
    Sci Rep; 2021 Sep; 11(1):19482. PubMed ID: 34593942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish.
    Albadri S; Del Bene F; Revenu C
    Methods; 2017 May; 121-122():77-85. PubMed ID: 28300641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of genome editing through CRISPR-Cas9 engineering.
    Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
    Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knock-in of large reporter genes in human cells via CRISPR/Cas9-induced homology-dependent and independent DNA repair.
    He X; Tan C; Wang F; Wang Y; Zhou R; Cui D; You W; Zhao H; Ren J; Feng B
    Nucleic Acids Res; 2016 May; 44(9):e85. PubMed ID: 26850641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Disruption Using CRISPR-Cas9 Technology.
    Hu N; Malek SN
    Methods Mol Biol; 2019; 1881():201-209. PubMed ID: 30350208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9 Technology in Translational Biomedicine.
    Leonova EI; Gainetdinov RR
    Cell Physiol Biochem; 2020 Apr; 54(3):354-370. PubMed ID: 32298553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational Selection of CRISPR-Cas9 Guide RNAs for Homology-Directed Genome Editing.
    Tatiossian KJ; Clark RDE; Huang C; Thornton ME; Grubbs BH; Cannon PM
    Mol Ther; 2021 Mar; 29(3):1057-1069. PubMed ID: 33160457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV; Lavrov AV
    Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical Control of Genome Editing by Photoactivatable Cas9.
    Otabe T; Nihongaki Y; Sato M
    Methods Mol Biol; 2021; 2312():225-233. PubMed ID: 34228293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A protocol for custom CRISPR Cas9 donor vector construction to truncate genes in mammalian cells using pcDNA3 backbone.
    Vazquez N; Sanchez L; Marks R; Martinez E; Fanniel V; Lopez A; Salinas A; Flores I; Hirschmann J; Gilkerson R; Schuenzel E; Dearth R; Halaby R; Innis-Whitehouse W; Keniry M
    BMC Mol Biol; 2018 Mar; 19(1):3. PubMed ID: 29540148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas9-Guided Genome Engineering in C. elegans.
    Kim HM; Colaiácovo MP
    Curr Protoc Mol Biol; 2016 Jul; 115():31.7.1-31.7.18. PubMed ID: 27366893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covalent linkage of the DNA repair template to the CRISPR-Cas9 nuclease enhances homology-directed repair.
    Savic N; Ringnalda FC; Lindsay H; Berk C; Bargsten K; Li Y; Neri D; Robinson MD; Ciaudo C; Hall J; Jinek M; Schwank G
    Elife; 2018 May; 7():. PubMed ID: 29809142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A CRISPR-Assisted Nonhomologous End-Joining Strategy for Efficient Genome Editing in Mycobacterium tuberculosis.
    Yan MY; Li SS; Ding XY; Guo XP; Jin Q; Sun YC
    mBio; 2020 Jan; 11(1):. PubMed ID: 31992616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Editing With TALEN and CRISPR/Cas in Rice.
    Bi H; Yang B
    Prog Mol Biol Transl Sci; 2017; 149():81-98. PubMed ID: 28712502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of genetically modified rat models via the CRISPR/Cas9 technology.
    Liu MZ; Wang LR; Li YM; Ma XY; Han HH; Li DL
    Yi Chuan; 2023 Jan; 45(1):78-87. PubMed ID: 36927640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. qEva-CRISPR: a method for quantitative evaluation of CRISPR/Cas-mediated genome editing in target and off-target sites.
    Dabrowska M; Czubak K; Juzwa W; Krzyzosiak WJ; Olejniczak M; Kozlowski P
    Nucleic Acids Res; 2018 Sep; 46(17):e101. PubMed ID: 29878242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.